المؤلفون: Oja, A E, Piet, B, Helbig, C, Stark, R, van der Zwan, D, Blaauwgeers, H, Remmerswaal, E B M, Amsen, D, Jonkers, R E, Moerland, P D, Nolte, M A, van Lier, R A W, Hombrink, P

المصدر: Mucosal Immunology ; volume 11, issue 3, page 654-667 ; ISSN 1933-0219

الاتاحة: http://dx.doi.org/10.1038/mi.2017.94
http://www.nature.com/articles/mi201794.pdf
http://www.nature.com/articles/mi201794
https://api.elsevier.com/content/article/PII:S1933021922005414?httpAccept=text/xml
https://api.elsevier.com/content/article/PII:S1933021922005414?httpAccept=text/plain
http://www.nature.com/doifinder/10.1038/mi.2017.94

المؤلفون: Kooijman, M., Van Der Zwan, D., Van Meer, P., Moors, E., Schellekens, H., Hekkert, M.

المساهمون: Innovation and Sustainability, Dynamics of Innovation Systems, Sub Drug delivery, Sub Immunopharmacology, Sub Biotechnological drugs, Sub General Pharmaceutics, Innovation Studies, Pharmaceutics

مصطلحات موضوعية: cosmetic, society, validation study, policy, risk assessment, cornea opacity, animal experiment, validation process, eye irritation, laboratory, skin, permeability, chicken, assay, eye, safety, gold standard, European Union, Taverne

وصف الملف: image/pdf

Relation: https://dspace.library.uu.nl/handle/1874/385314

الاتاحة: https://dspace.library.uu.nl/handle/1874/385314

المؤلفون: Van der Bij, A.K., Van der Zwan, D., Peirano, G., Severin, J.A., Pitout, J.D.D., Van Westreenen, M., Goessens, W.H.F.

المصدر: Clinical Microbiology and Infection ; volume 18, issue 9, page E369-E372 ; ISSN 1198-743X

الاتاحة: http://dx.doi.org/10.1111/j.1469-0691.2012.03969.x
https://api.elsevier.com/content/article/PII:S1198743X14610557?httpAccept=text/xml
https://api.elsevier.com/content/article/PII:S1198743X14610557?httpAccept=text/plain

المؤلفون: Oja, A E, Piet, B, Helbig, C, Stark, R, van der Zwan, D, Blaauwgeers, H, Remmerswaal, E B M, Amsen, D, Jonkers, R E, Moerland, P D, Nolte, M A, van Lier, R A W, Hombrink, P

المصدر: Mucosal Immunology (1933-0219); May2018, Vol. 11 Issue 3, p654-667, 14p

المؤلفون: Oja, A E, Piet, B, Helbig, C, Stark, R, van der Zwan, D, Blaauwgeers, H, Remmerswaal, E B M, Amsen, D, Jonkers, R E, Moerland, P D, Nolte, M A, van Lier, R A W, Hombrink, P

المصدر: Mucosal Immunology; May 2018, Vol. 11 Issue: 3 p654-667, 14p

المؤلفون: Innovation and Sustainability, Dynamics of Innovation Systems, Sub Drug delivery, Sub Immunopharmacology, Sub Biotechnological drugs, Sub General Pharmaceutics, Innovation Studies, Pharmaceutics, Kooijman, M., Van Der Zwan, D., Van Meer, P., Moors, E., Schellekens, H., Hekkert, M.

URL: http://hdl.handle.net/1874/385314
https://dspace.library.uu.nl/handle/1874/385314
0261-1929
ATLA : Alternatives to Laboratory Animals
40
4
A15
A16